Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Emiko Niiro is active.

Publication


Featured researches published by Emiko Niiro.


Archives of Gynecology and Obstetrics | 2014

Mechanism of pain generation for endometriosis-associated pelvic pain.

Hiroshi Kobayashi; Yuki Yamada; Sachiko Morioka; Emiko Niiro; Aiko Shigemitsu; Fuminori Ito

PurposeEndometriosis-associated pelvic pain appears due to persistent nociceptive stimulation, but the precise mechanisms remain poorly understood.MethodsA search was conducted to screen and select articles from PubMed.Main resultsNeurotrophins (NTs), a family of neuronal growth factors, are overexpressed in endometriosis and encompass NGF, BDNF and NT-3 and NT-4/5. NT receptors, TrkA and p75NTR, and NT receptor-interacting proteins, MAGE and NDN, were also expressed. NTs and their receptors play a role in the development and maintenance of neural tissues in non-neuronal cell types such as endometriosis. Nerve fibers contain unmyelinated sensory C, myelinated sensory Adelta and adrenergic nerve fibers that innervate abnormal cell growths. An increased release of proinflammatory cytokines from endometriotic lesions is responsible for the excessive sensory innervation and development of chronic pelvic pain.ConclusionsThe preponderance of the inflammatory milieu and subsequent hyperinnervation might be involved in the pathophysiology of pain generation in women with endometriosis.


Human Immunology | 2014

Fetal programming theory: Implication for the understanding of endometriosis

Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada

Comparison of the transcriptomes and proteomes of the decidualization-specific genes that express high vs low levels of the eutopic and ectopic endometrium of women with endometriosis compared with controls, could be useful in understanding the pathogenesis of endometriosis. Genome-wide comparison between decidual tissue and non-decidual tissue identified many genes significantly modulated in the process of decidualization. Comparison of eutopic endometrium and endometriotic sites also revealed up- and down-regulated genes. A combined analysis of the experimental data showed specific genes up-regulated both at the endometriotic site and in the decidualization process, representing a broad diversity of molecular functions, including cell cycle regulation, angiogenesis and adhesion molecules. In contrast, down-regulated genes identified in endometriosis among genes overexpressed in decidualization encode Müllerian embryogenesis, which includes transcription factors, hormonal regulation and cytokine expression. The mechanism responsible for insufficient decidualization in endometriosis may be mediated through down-regulation of the Müllerian embryogenesis-related genes. In conclusion, a range of decidualization resistance has been associated with endometriosis. Future study will identify the putative mechanisms relating epigenetic changes of decidualization susceptibility genes in early life to the risk of developing endometriosis in adulthood.


Journal of Obstetrics and Gynaecology Research | 2017

Skin–mucous membrane disorder and therapeutic effect of pegylated liposomal doxorubicin in recurrent ovarian cancer

Yuki Yamada; Ryuji Kawaguchi; Fuminori Ito; Kana Iwai; Emiko Niiro; Hiroshi Shigetomi; Yasuhito Tanase; Hiroshi Kobayashi

Hand–foot syndrome (HFS) induced by chemotherapy and molecule‐targeting drugs is correlated with treatment efficacy. We conducted a retrospective analysis to evaluate the relationship between HFS and efficacy of pegylated liposomal doxorubicin (PLD) for recurrent ovarian cancer.


Free Radical Research | 2017

Sequential molecular changes and dynamic oxidative stress in high-grade serous ovarian carcinogenesis

Hiroshi Kobayashi; Kenji Ogawa; Naoki Kawahara; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada

Abstract The mechanism of high-grade serous ovarian cancer (HGSC) development remains elusive. This review outlines recent advances in the understanding of sequential molecular changes associated with the development of HGSC, as well as describes oxidative stress-induced genomic instability and carcinogenesis. This article reviews the English language literature between 2005 and 2017. Clinicopathological features analysis provides a sequential progression of fallopian tubal epithelium to precursor lesions to type 2 HGSC. HGSC may develop over a long time after incessant ovulation and repeated retrograde menstruation via stepwise accumulation of genetic alterations, including PAX2, ALDH1A1, STMN1, EZH2 and CCNE1, which confer positive selection of cells with growth advantages through acquiring driver mutations such as BRCA1/2, p53 or PTEN/PIK3CA. Haemoglobin and iron-induced oxidative stress leads to the emergence of genetic alterations in fallopian tubal epithelium via increased DNA damage and impaired DNA repair. Serous tubal intraepithelial carcinoma (STIC), the likely precursor of HGSC, may be susceptible to DNA double-strand breaks, exhibit DNA replication stress and increase genomic instability. The induction of genomic instability is considered to be a driving mechanism of reactive oxygen species (ROS)-induced carcinogenesis. HGSC exemplifies the view of stepwise cancer development. We describe how genetic alterations emerge during HGSC carcinogenesis related to oxidative stress.


Reproductive Sciences | 2014

Genes Downregulated in Endometriosis Are Located Near the Known Imprinting Genes

Hiroshi Kobayashi; Yumi Higashiura; Natsuki Koike; Juria Akasaka; Chiharu Uekuri; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada

There is now accumulating evidence that endometriosis is a disease associated with an epigenetic disorder. Genomic imprinting is an epigenetic phenomenon known to regulate DNA methylation of either maternal or paternal alleles. We hypothesize that hypermethylated endometriosis-associated genes may be enriched at imprinted gene loci. We sought to determine whether downregulated genes associated with endometriosis susceptibility are associated with chromosomal location of the known paternally and maternally expressed imprinting genes. Gene information has been gathered from National Center for Biotechnology Information database geneimprint.com. Several researchers have identified specific loci with strong DNA methylation in eutopic endometrium and ectopic lesion with endometriosis. Of the 29 hypermethylated genes in endometriosis, 19 genes were located near 45 known imprinted foci. There may be an association of the genomic location between genes specifically downregulated in endometriosis and epigenetically imprinted genes.


Biomedical Reports | 2018

Conceptual frameworks of synthetic lethality in clear cell carcinoma of the ovary (Review)

Hiroshi Kobayashi; Naoki Kawahara; Kenji Ogawa; Yuki Yamada; Kana Iwai; Emiko Niiro; Sachiko Morioka

Targeting non-oncogenes may result in the selective death of cancer cells. Clear cell carcinoma of the ovary (CCC) may exhibit resistance against conventional chemotherapy and is associated with poor prognosis. The aim of the present report was to review synthetic lethality-based therapies for CCC. Previous English-language studies were reviewed to accumulate preclinical and clinical data on targeting synthetic lethal partners. Synthetic lethal interactions have a variety of types, involving components of a backup or parallel pathway with overlapping functions, components encoded by paralogous pairs, subunit components that form heteromeric complexes and components that are arranged in a single linear pathway. A set of candidate gene targets potentially resulting in synthetic lethality have been previously identified. HNF class homeobox, AT-rich interaction domain 1A, ATR serine/threonine kinase, ATM serine/threonine kinase, checkpoint kinase 1 and phosphatase and tensin homolog may be the key partner genes. A variety of loss of function genes in CCC are driver or passenger events and may function as synthetic lethal pairs under replication stress conditions. Further clinical studies will be required to investigate the safety and therapeutic effect of synthetic lethality pairs in CCC tumor types with replication stress.


Biomedical Reports | 2018

Potential signaling pathways as therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer (Review)

Emiko Niiro; Sachiko Morioka; Kana Iwai; Yuki Yamada; Kenji Ogawa; Naoki Kawahara; Hiroshi Kobayashi

Cases of mucinous ovarian cancer are predominantly resistant to chemotherapies. The present review summarizes current knowledge of the therapeutic potential of targeting the Wingless (WNT) pathway, with particular emphasis on preclinical and clinical studies, for improving the chemoresistance and treatment of mucinous ovarian cancer. A review was conducted of English language literature published between January 2000 and October 2017 that concerned potential signaling pathways associated with the chemoresistance of mucinous ovarian cancer. The literature indicated that aberrant activation of growth factor and WNT signaling pathways is specifically observed in mucinous ovarian cancer. An evolutionarily conserved signaling cascade system including epidermal growth factor/RAS/RAF/mitogen-activated protein kinase kinase/extracellular signal-regulated protein kinase, phosphoinositide 3-kinase/Akt and WNT signaling regulates a variety of cellular functions; their crosstalk mutually enhances signaling activity and induces chemoresistance. Novel antagonists, modulators and inhibitors have been developed for targeting the components of the WNT signaling pathway, namely Frizzled, low-density lipoprotein receptor-related protein 5/6, Dishevelled, casein kinase 1, AXIN, glycogen synthase kinase 3β and β-catenin. Targeted inhibition of WNT signaling represents a rational and promising novel approach to overcome chemoresistance, and several WNT inhibitors are being evaluated in preclinical studies. In conclusion, the WNT receptors and their downstream components may serve as novel therapeutic targets for overcoming chemoresistance in mucinous ovarian cancer.


Biomedical Reports | 2017

The conceptual advances of carcinogenic sequence model in high‑grade serous ovarian cancer (Review)

Hiroshi Kobayashi; Kana Iwai; Emiko Niiro; Sachiko Morioka; Yuki Yamada; Kenji Ogawa; Naoki Kawahara


Hypertension Research in Pregnancy | 2014

Placental abruption with certified fetomaternal hemorrhage after traffic injury

Haruki Nakamura; Yuki Yamada; Juria Akasaka; Emiko Niiro; Katsuhiko Naruse; Hiroshi Kobayashi


Japanese Journal of Gynecologic and Obstetric Endoscopy | 2017

A Rare Case of Eggshell-Mimicking Omental Teratoma Treated with Laparoscopic Surgery

Sachiko Morioka; Yasuhito Tanase; Kana Iwai; Emiko Niiro; Yuki Yamada; Natsuki Koike; Ryuji Kawaguchi; Hiroshi Kobayashi

Collaboration


Dive into the Emiko Niiro's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuki Yamada

Nara Medical University

View shared research outputs
Top Co-Authors

Avatar

Kana Iwai

Nara Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Kenji Ogawa

Nara Medical University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Fuminori Ito

Nara Medical University

View shared research outputs
Researchain Logo
Decentralizing Knowledge